Amerise Biosciences share news, announcements and annual reports
BSE: 531681Industrial ProductsSmall Cap
AMERISE BIOSCIENCES LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1996
Last close ₹0.84up ₹0.02 (2.44%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹0.82.
2 Nov: open ₹0.82, high ₹0.86, low ₹0.78
52-week range of traded prices to 2 Nov 2026
₹0.50Low, 4 Mar 2026₹1.03High, 3 Aug 2026
- Under BSE's graded surveillance, stage 0, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5.55 Cr5,065th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.06
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −1.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 71,535
Amerise Biosciences board meetings
92 filed, newest first. Page 2 of 2.
May 2022
Feb 2022
Jan 2022
25 Jan · Board meeting
Meeting on 14 Feb 2022: quarterly results
Nov 2021
Oct 2021
28 Oct · Board meeting
Meeting on 12 Nov 2021: quarterly results
Aug 2021
4 Aug · Board meeting
Meeting on 10 Aug 2021: quarterly results
May 2021
10 May · Board meeting
Meeting on 20 May 2021: audited results
Jan 2021
25 Jan · Board meeting
Meeting on 2 Feb 2021: quarterly results
Oct 2020
20 Oct · Board meeting
Meeting on 26 Oct 2020: quarterly results
Aug 2020
26 Aug · Board meeting
Meeting on 1 Sep 2020: quarterly results
Jun 2020
5 Jun · Board meeting
Meeting on 18 Jun 2020: audited results3 Jun · Board meeting
Meeting on 9 Jun 2020: audited resultsNot held on this date
Jan 2020
20 Jan · Board meeting
Meeting on 3 Feb 2020: quarterly results
Oct 2019
15 Oct · Board meeting
Meeting on 24 Oct 2019: quarterly results
Jul 2019
19 Jul · Board meeting
Meeting on 29 Jul 2019: quarterly results
Jun 2019
May 2019
14 May · Board meeting
Meeting on 23 May 2019: audited results
Mar 2019
19 Mar · Board meeting
Meeting on 19 Mar 2019
Jan 2019
24 Jan · Board meeting
Meeting on 1 Feb 2019: quarterly results
Sep 2017
Aug 2015
19 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 19, 2015, inter alia, considered the following: - To Appoint Ms. ....
Aug 2014
27 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 27, 2014, has considered the following: 1. The Board has decided ....
Jun 2014
4 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 04, 2014, inter alia, has considered the following: - To Appoint Mr. ....
Dec 2012
17 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 15, 2012, have approved the Scheme of Amalgamation of Vishal Reality ....
Jun 2012
Jan 2011
13 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 13, 2011, inter alia, decided to amalgamate the Company Zoriion Communication ....
Feb 2010
19 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 19, 2010, has taken the following decisions: 1. Mr. Nilesh Kava, ....